United States· US:65145-176_a2822b12-0560-49d6-ace5-2377c04425e8
Milrinone Lactate in 5% Dextrose
A milrinone product containing milrinone lactate in 5% dextrose, registered in United States by Caplin Steriles Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Milrinone is registered in 16 of 19 countries.
Countries holding a registration under ATC C01CE02 (milrinone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Milrinone · ATC C01CE02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Milrinone Lactate in 5% Dextrose
- Manufacturer
- Caplin Steriles Limited
- Country
- United States (US)
- ATC code
- C01CE02
- ATC class
- Milrinone
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1165145176011 BAG in 1 POUCH (65145-176-01) / 100 mL in 1 BAG
Regulatory notes
Interactions
5 interactions on record for milrinone.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Milrinone · interactions on record
5 records
- 5 moderate
Most severe, free to view
- ProcarbazineL01XB01moderate
- AnagrelideL01XX35moderate
- OzanimodL04AA38moderate
- OzanimodL04AE02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Milrinone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMilrinone 10mg/10ml concentrate for solution for infusion ampoulesStragen UK Ltd
- GermanyCorotropSanofi-Aventis Deutschland Gmbh
- FranceCOROTROPE 10 mg/10 ml, solution injectable IVSANOFI WINTHROP INDUSTRIE
- Japanミルリノン日医工岐阜工場
- FinlandMilnifarmOrifarm Oy
- NetherlandsMilrinon Carinopharm 1 mg/ml oplossing voor injectie/infusieCarinopharm GmbH
- BelgiumCorotrope 1 mg/mlSanofi Belgium
- SwedenCorotrop 1 mg/ml Injektionsvätska, lösningSanofi AB
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Asicor, Milrinon Carino
- Belgium · Corotrope
- Bulgaria · Milrinon Makpharm
- Czechia · Asicord, Corotrop
- Germany · Corotrop, Milrinon Carinopharm
- Denmark · Milnocor, Milrinon Stragen
- Spain · Corotrope, Milrinone
- Finland · Milnocor, Milrinon Stragen
- France · Corotrope, Milrinone Carinopharm
- United Kingdom (Northern Ireland) · Milrinone Carinopharm, Milrinone Macure Pharma Uk
- Greece · Corotrope
- Croatia · Milrinon Makpharm
- Hungary · Corotrope, Unacor
- Ireland · Milrinone Pinewood Laboratories
- Luxembourg · Corotrope
- Malta · Milrinone Tillomed
- Netherlands · Milrinon Carinopharm, Milrinon Devrimed
- Norway · Milnocor, Milrinon Stragen
- Poland · Asicor, Corotrope
- Portugal · Corotrope
- Romania · Milrinone Zentiva, Unacor
- Sweden · Corotrop, Milrinon Carinopharm
- Slovenia · Milrinon Makpharm
- Slovakia · Asicord, Corotrope Inj
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/70f415ad-4a70-4fa5-bc65-081bbfe92e21 GET /v1/drugs/70f415ad-4a70-4fa5-bc65-081bbfe92e21?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "9K8XR81MO8",
"rxcui": "155120",
"inchikey": "VWUPWEAFIOQCGF-UHFFFAOYSA-N",
"display_name": "MILRINONE LACTATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"4c2f052b-7ba2-4122-a50b-37ef2a834d61": {
"match": "brand_token",
"title": "MILRINONE LACTATE IN DEXTROSE INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.]",
"spl_version": "8",
"published_date": "2026-05-20"
}
},
"productid": "65145-176_a2822b12-0560-49d6-ace5-2377c04425e8",
"productndc": "65145-176",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "219170",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)",
"product_no": "001",
"approval_date": "Sep 2, 2025"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)",
"product_no": "002",
"approval_date": "Sep 2, 2025"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "MILRINONE LACTATE",
"proprietary_name": "Milrinone Lactate in 5% Dextrose",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA219170",
"marketing_category": "ANDA",
"nonproprietary_name": "Milrinone Lactate in 5% Dextrose",
"start_marketing_date": "20250913",
"active_numerator_strength": ".2"
}See everything about milrinone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.